Research demonstrates improved therapeutic outcomes in glioblastoma by reversing anoikis resistance with thermoradiotherapy, suggesting enhanced efficacy with MRI guidance.
Motivation: Glioblastoma multiforme is a highly aggressive cancer, of which anoikis resistance contributes to the strong resistance to standard therapies resulting in a poor prognosis. Goal(s): MRI-guided thermoradiotherapy is an attractive and innovative strategy for treating GBM, offering superior biocompatibility and therapeutic efficacy compared to conventional therapies. Approach: Herein, we synthesized Gd-MNP-PEGs that present excellent MR imaging ability, photothermal conversion capability, and radiosensitizing effect. Results: It contributes to i) MR imaging of GBM to identify tumor boundaries, ii) radiosensitizing GBM with photothermal therapy to inhibit the proliferation and metastasis of GBM, iii) reversing anoikis resistance via thermoradiotherapy to improve therapeutic outcomes. Impact: This study presents biocompatible nanoplatforms that allow MR imaging, high anti-tumor thermoradiotherapy efficacy, and negligible side effects in the treatment of GBM.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: